Tesamorelin vs HGH 191AA: What’s the Difference?
The main difference between Tesamorelin and HGH 191AA is mechanism: Tesamorelin is studied for visceral fat reduction research — Stabilized GHRH analog. HGH 191AA is studied for reference growth hormone research — Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
GHRH analog vs exogenous recombinant GH.
Key differences between Tesamorelin and HGH 191AA
- •Mechanism: Tesamorelin — Stabilized GHRH analog. HGH 191AA — Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
- •Primary research focus: Tesamorelin is studied for visceral fat reduction research; HGH 191AA is studied for reference growth hormone research.
- •Overlap: the two compounds share muscle growth & performance.
- •Discussion context: Tesamorelin is most often discussed alongside visceral fat reduction research, while HGH 191AA centres on reference growth hormone research.
| Attribute | Tesamorelin Stabilized GHRH analog | HGH 191AA Recombinant Human Growth Hormone |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Visceral fat reduction research | Reference growth hormone research |
| Mechanism of action | Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat. | Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis. |
| Human research | Strong | Not catalogued |
| Animal research | Moderate | Not catalogued |
| Mechanistic research | Established | Not catalogued |
| Study cadence cited | Daily, typically evening | — |
| In plain English | Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically. | The real thing. Where peptides stimulate the body to make more GH, HGH 191AA is the GH molecule itself. |
| How it works | Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue. | Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis. |
| Researchers study | Visceral fat reduction, lipid metabolism, and cognitive function in older adults. | GH deficiency, body composition, recovery, and longevity. |
| Internet discussion | Discussed by people specifically targeting belly fat. | Long-running anti-aging discussion topic. |
Mechanism and research evidence, side by side
How Tesamorelin and HGH 191AA differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
Tesamorelin
Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Strong
- Animal research
- Moderate
- Mechanistic research
- Established
Visceral fat reduction (particularly abdominal), GH/IGF-1 increase
Tesamorelin
Visceral fat reduction research
Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically.
Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue.
Visceral fat reduction, lipid metabolism, and cognitive function in older adults.
Discussed by people specifically targeting belly fat.
Tesamorelin is the GHRH analog with strongest data for reducing visceral fat specifically.
HGH 191AA
Reference growth hormone research
The real thing. Where peptides stimulate the body to make more GH, HGH 191AA is the GH molecule itself.
Binds the GH receptor across tissues, stimulating IGF-1 production, lipolysis, and protein synthesis.
GH deficiency, body composition, recovery, and longevity.
Long-running anti-aging discussion topic.
HGH 191AA is recombinant human growth hormone — the reference standard for GH research.